Regarding: Van Diessen et al., "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced non-small cell lung cancer (NSCLC) patients"

Radiother Oncol. 2020 Jun:147:243-244. doi: 10.1016/j.radonc.2020.03.034. Epub 2020 Apr 3.

Authors

Jongmoo Park¹, Ji Woon Yea², Jae Won Park², Jaehyeon Park³

Affiliations

¹ Department of Radiation Oncology, Kyungpook National University Chilgok Hospital, Daegu, South Korea.
² Department of Radiation Oncology, Yeungnam University College of Medicine, Daegu, South Korea.
³ Department of Radiation Oncology, Yeungnam University College of Medicine, Daegu, South Korea. Electronic address: drjhyeon@ynu.ac.kr.

PMID: 32312602
DOI: 10.1016/j.radonc.2020.03.034

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / pathology
Humans
Lung Neoplasms* / pathology
Lymph Nodes / pathology
Lymphatic Metastasis
Neoplasm Staging